Publicacións en colaboración con investigadores/as de Hospital Universitario La Fe (19)

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  2. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  3. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

2019

  1. A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain

    Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567

  2. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study

    Transplant International, Vol. 32, Núm. 3, pp. 313-322

  3. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

  4. Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study

    Nefrologia, Vol. 39, Núm. 2, pp. 151-159

  5. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

    Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665

  6. Reply to: “Normothermic regional perfusion – What is the benefit?”

    Journal of Hepatology

  7. The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

    Journal of Hepatology

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

2015

  1. Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus

    Transplantation Direct, Vol. 1, Núm. 7, pp. E24

  2. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2014

  1. Liver transplantation for bile duct injury after open and laparoscopic cholecystectomy

    British Journal of Surgery, Vol. 101, Núm. 2, pp. 63-68

2013

  1. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32